Last reviewed · How we verify
NCT03041493
Investigation of the Effects of Electronic Cigarettes on Vascular Health
NA trial testing Electronic cigarette in Vascular Health in 12 participants. Terminated before completion.
11 June 2021
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 12 |
| Start date | 1 February 2017 |
| Primary completion | 11 June 2021 |
| Estimated completion | 11 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Electronic cigarette — full drug profile →
- traditional cigarette
- (sham cigarette) - no actual exposure to cigarettes
Conditions studied
- Vascular Health — all drugs for Vascular Health →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
Adults 18 to 50, any sex, with Vascular Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal is find out if the use of Electronic cigarettes (EC) leads to the same changes that we see in blood vessels of traditional cigarettes (TC) users. The investigators will also enroll non-smokers as "controls", against which they will measure changes in blood vessels in TC and EC users.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03041493
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electronic cigarette
Trials testing the same drug.
- NCT05703672 — Switching to E-cigarettes in Smokers Not Interested in Quitting · Phase 3 · recruiting
Other recruiting trials for Vascular Health
Currently open trials in the same condition.
- NCT07397754 — Sodium-rich COndiments Unifying Health and Taste · NA · recruiting
- NCT06745063 — Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity · Phase 2 · recruiting
- NCT06912984 — Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men · NA · recruiting
- NCT07481578 — Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of · NA · recruiting
- NCT06535178 — The Influence of Sleep on Cardiovascular Outcomes · NA · recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03041493 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 18 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03041493.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing